Health Trials

Effect of Alternate Day Fasting Over Standard Medical Management Alone to Reverse Non-alcoholic Steatohepatitis.

ConditionNon Alcoholic Steatohepatitis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorInstitute of Liver and Biliary Sciences, India

About this trial

The aims of this study are as follows: To compare the role of alternate-day fasting over standard medical management alone to reverse NASH.

Eligibility criteria

Qualifiers

Age 18-65 years. BMI 25-40kg/m3, and CAP more than 290

Stable weight in the last 3 months prior to enrolling in the study(<5kg weight variation)

Imaging showed steatotic liver disease, liver stiffness <14kPa measured by fibroscan

Histologically proven NASH/MASH, fibrosis up to F3

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Alternate day fasting

Treatment groups

72 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Institute of Liver and Biliary Sciences, India

Lead sponsor

Source ClinicalTrials.gov